solventum.com (SOLV): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
Solventum Corporation 3M kompaniyasidan ajralganidan so'ng taqsimot zanjirlarini optimallashtirgan holda, tibbiy texnologiyalar va sarf materiallarining yetkazib berilishiga tayanadi. P/E koeffitsiyentining o'sish tendentsiyasi aksiyalar narxi va foyda o'rtasidagi muvozanatni ifodalaydi, bunda 1.04 ushbu parametrning joriy holatini belgilaydi. Innovatsion filtrlarning global sotuvlarini kengaytirish barqaror daromad oqimini ta'minlaydi, institutlar bilan hamkorlik esa davolash xavfsizligini oshiradi.
Solventum Corporation (SOLV) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Solventum Corporation|SOLV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati solventum.com|SOLV - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati Solventum Inc.|SOLV - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Solventum|Shoshilinch likvidlik koeffitsiyenti solventum.com
- foyda va bozor koeffitsiyentlari statistikasi:
SOLV - Sof daromad|Kelajakdagi sof foyda Solventum Corporation|SOLV - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Solventum Health|SOLV - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Solventum Inc.|SOLV - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Solventum|SOLV - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi solventum.com|SOLV - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Solventum Corporation
Kompaniyaning jamlanma tahliliyoti:Solventum Corp SOLV
Tibbiy sarflanadigan materiallar yetkazib berishdan olinadigan barqaror pul oqimlariga tayanadigan Solventum Corporation (SOLV) uchun ushbu koeffitsient sof foyda dinamikasiga nisbatan bozor qiymatining adolatli ekanligini belgilaydi. Ushbu o'sish aksiyalari jozibadorligi ko'rsatkichini tahlil qilish orqali investor P/E multiplikatorini biznesning kengayish sur'atlari bilan solishtiradi: birdan past qiymatlar aktivning yuqori operatsion momentumni saqlagan holda qadrsizlanganligini anglatadi.
Raqobatdosh kompaniyalar
HCA - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Tenet THC|FMS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|EHC: Narx-foyda va o‘sish multiplikatori|Universal Health Services - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|DaVita (DVA) - Narxning foydaga va o‘sish sur’atiga nisbati|RDNT - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Option Care Health Inc|O‘sish sur’atiga tuzatilgan narx-foyda Surgery Partners Group SGRY|Narxning foydaga va o‘sish sur’atiga nisbati Premier, Inc. (PINC)|Narxning foydaga va o‘sish sur’atiga nisbati EYE (nationalvision.com)|Progyny - Narx-foyda va o‘sish multiplikatori|Ardent Health - Narxning foydaga va o‘sish sur’atiga nisbati|Select Medical Corp - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Astrana Corp|mednax.com (MD) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti USPH|Narx-foyda va o‘sish multiplikatori PNTG|ORGO (Organogenesis Holdings Inc.) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori NUTX (Nutex Health Corp)|PEG multiplikatori Auna Corp (AUNA)|Narxning foydaga va o‘sish sur’atiga nisbati SBC Medical Group Holdings Inc SBC|EOLS - Narx-foyda va o‘sish multiplikatori|CYH: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti SKIN (The Beauty Health)|MDWD: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Biote Corporation|Narxning foydaga va o‘sish sur’atiga nisbati The Joint Corp.|O‘sish sur’atiga tuzatilgan narx-foyda docgo.com DCGO|Narxning foydaga va o‘sish sur’atiga nisbati P3 Health Partners Inc. (PIII)|GANX (Gain Therapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati EUDA Health EUDA|BMGL (Basel Medical) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|CLGN - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda cuprina.com.sg|Concord Medical (CCM) - Narxning foydaga va o‘sish sur’atiga nisbati|American Shared Hospital Services Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|MRM (MEDIROM Healthcare Group Inc) - PEG multiplikatori|PEG multiplikatori Avalon GloboCare Corporation|Narx-foyda va o‘sish multiplikatori DHAI (DIH Holding US, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati XAGE|PEG multiplikatori NIVF (NewGenIvf)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati ATI Physical Therapy Inc. (ATIP)|CMAX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Kindly Health|ModivCare Inc. (MODV) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NVOS|Narxning foydaga va o‘sish sur’atiga nisbati SunLink Health Systems Inc.|IMAC Holdings Inc (BACK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
